Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration
The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Abstract
Factors contributing to retroviral integration have been intractable because past studies have not precisely located genomic sites of proviruses in sufficient numbers for significant analysis. In this study, 903 murine leukemia virus (MLV) and 379 human immunodeficiency virus–1 (HIV-1) integrations in the human genome were mapped. The data showed that MLV preferred integration near the start of transcriptional units (either upstream or downstream) whereas HIV-1 preferred integration anywhere in the transcriptional unit but not upstream of the transcriptional start. Defining different integration site preferences for retroviruses will have important ramifications for gene therapy and may aid in our understanding of the factors directing the integration process.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The well-understood integration preferences of HIV-1 for active transcription units72 and MLV for promoter/enhancer regions73–75 are in large part dictated via specific interactions of the respective IN proteins with chromatin-bound host factors.”
From Structure and function of retroviral integrase (2022) · cites this paper as [73]
In the citing paper
“Multiple studies now indicate that gammaretroviral vectors such as the vectors used in the two SCID-X1 trials preferentially integrate into the 5′ end of genes, near the transcription start sites[47].”
From Finding the needle in the hay stack: Hematopoietic stem cells in Fanconi anemia (2009) · cites this paper as [47]
In the citing paper
“Finally, the preferred sequences of the genome for integration are different from the γ-RVV, with LVV preferentially integrating in genes and introns away for transcriptional start sites preferred by γ-RVV.20”
From Ex vivo modification of hematopoietic stem and progenitor cells for gene therapy (2025) · cites this paper as [20]
Citations
Cites
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. D. S., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.-L., et al. (2000) · Science · doi:10.1126/science.288.5466.669 · Cited by 2,167
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy
Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.-P., Thrasher, A. J., Wulffraat, N., Sorensen, R., Dupuis-Girod, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012616 · Cited by 1,058
CpG islands as gene markers in the human genome
Larsen, F., Gundersen, G., Lopez, R., & Prydz, H. (1992) · Genomics · doi:10.1016/0888-7543(92)90024-m · Cited by 922
Pryciak, P. M., & Varmus, H. E. (1992) · Cell · doi:10.1016/0092-8674(92)90289-o · Cited by 273
Introducing RefSeq and LocusLink: curated human genome resources at the NCBI
Pruitt, K. D., Katz, K. S., Sicotte, H., & Maglott, D. R. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01882-x · Cited by 241
Check, E. (2002) · Nature · doi:10.1038/420116a · Cited by 238
Pruss, D., Bushman, F. D., & Wolffe, A. P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.5913 · Cited by 236
Transcriptionally active genome regions are preferred targets for retrovirus integration
Scherdin, U., Rhodes, K., & Breindl, M. (1990) · Journal of Virology · doi:10.1128/jvi.64.2.907-912.1990 · Cited by 210
Research works printed but not linked: 2
- National Center for Biotechnology Information Reference Sequence Project (RefSeq) www.ncbi.nlm.nih.gov/RefSeq/.
- The database is available online at www.ncbi.nlm.nih.gov/geo/.
Cited by
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Mobile Elements: Drivers of Genome Evolution
Kazazian, H. H. (2004) · Science · doi:10.1126/science.1089670 · Cited by 1,922
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Hacein-Bey-Abina, S., Garrigue, A., Wang, G. P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35700 · Cited by 1,854
“A duplication at 6q22-23 was also detected in P4 (Figure 6C), consistent with the unbalanced translocation t(6;13) that was previously reported (5).”
BackgroundDunbar, C. E., High, K. A., Joung, J. K., Kohn, D. B., Ozawa, K., & Sadelain, M. (2018) · Science · doi:10.1126/science.aan4672 · Cited by 1,410
Viral vector platforms within the gene therapy landscape
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404
Howe, S. J., Mansour, M. R., Schwarzwaelder, K., Bartholomae, C., Hubank, M., Kempski, H., Brugman, M. H., Pike-Overzet, K., Chatters, S. J., de Ridder, D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35798 · Cited by 1,286
Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences
Mitchell, R. S., Beitzel, B. F., Schroder, A. R. W., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020234 · Cited by 976
“A previous study revealed that integration by MLV is favored near transcription start sites, but no such bias was seen for HIV (Wu et al. 2003).”
BackgroundMethodResultInfluentialA Transposon-Mediated Gene Trap Approach Identifies Developmentally Regulated Genes in Zebrafish
Kawakami, K., Takeda, H., Kawakami, N., Kobayashi, M., Matsuda, N., & Mishina, M. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.06.005 · Cited by 849
“Linearized pBluescript (Stratagene) DNA was used as the backbone plasmid probe.proviral insertions (Golling et al., 2002), although the retrovirus preferentially integrates in the transcription start region of genes (Wu et al., 2003).”
BackgroundMethodMontini, E., Cesana, D., Schmidt, M., Sanvito, F., Ponzoni, M., Bartholomae, C., Sergi, L. S., Benedicenti, F., Ambrosi, A., Di Serio, C., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1216 · Cited by 701
Integrase inhibitors to treat HIV/Aids
Pommier, Y., Johnson, A. A., & Marchand, C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1660 · Cited by 688
“, whereas murine leukaemia virus (MLV) integrates preferentially in transcription start region”
BackgroundGene therapy in a patient with sickle cell disease
Ribeil, J.-A., Hacein-Bey-Abina, S., Payen, E., Magnani, A., Semeraro, M., Magrin, E., Caccavelli, L., Neven, B., Bourget, P., El Nemer, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609677 · Cited by 696
A role for LEDGF/p75 in targeting HIV DNA integration
Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R., & Bushman, F. (2005) · Nature Medicine · doi:10.1038/nm1329 · Cited by 658
Towards safe, non-viral therapeutic gene expression in humans
Glover, D. J., Lipps, H. J., & Jans, D. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1577 · Cited by 598
“However, it has recently become obvious that both MLV and lentivirus preferentially integrate into transcriptionally active regions of the genom”
BackgroundMontini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C. C., Ranzani, M., Benedicenti, F., Sergi, L. S., Ambrosi, A., Ponzoni, M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37630 · Cited by 571
“Because the LV tested differed from γ RV in both the molecular design (12, 13) and the integration site selection (ISS) (14–17), the relative contribution of these features to the lower genotoxicity of LV remained unknown.”
InfluentialDNA Transposons: Nature and Applications in Genomics
Munoz-Lopez, M., & Garcia-Perez, J. (2010) · Current Genomics · doi:10.2174/138920210790886871 · Cited by 447
“For example, viral vectors may induce a destructive immune response [150, 151], their production is difficult and expensive [152, 153], they prefer to integrate within 5’UTR regions of genes which may induce oncogenesis [150, 154, 155], and they have a relatively limited cargo capacity (less than 8 kb in lentivirus, r…”
BackgroundGene transfer in humans using a conditionally replicating lentiviral vector
Levine, B. L., Humeau, L. M., Boyer, J., MacGregor, R.-R., Rebello, T., Lu, X., Binder, G. K., Slepushkin, V., Lemiale, F., Mascola, J. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608138103 · Cited by 501
Entering the Modern Era of Gene Therapy
Anguela, X. M., & High, K. A. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-012017-043332 · Cited by 471
“This is in part due to differences in integration patterns, as γ-retroviral vectors tend to integrate near the start of transcriptional units whereas lentiviral vectors tend to integrate randomly in the transcriptional unit but not upstream of the transcriptional start (20).”
BackgroundMammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system
Dupuy, A. J., Akagi, K., Largaespada, D. A., Copeland, N. G., & Jenkins, N. A. (2005) · Nature · doi:10.1038/nature03691 · Cited by 482
Shun, M.-C., Raghavendra, N. K., Vandegraaff, N., Daigle, J. E., Hughes, S., Kellam, P., Cherepanov, P., & Engelman, A. (2007) · Genes & Development · doi:10.1101/gad.1565107 · Cited by 467
Suppression of lung adenocarcinoma progression by Nkx2-1
Winslow, M. M., Dayton, T. L., Verhaak, R. G. W., Kim-Kiselak, C., Snyder, E. L., Feldser, D. M., Hubbard, D. D., DuPage, M. J., Whittaker, C. A., Hoersch, S., et al. (2011) · Nature · doi:10.1038/nature09881 · Cited by 467
Host Cell Factors in HIV Replication: Meta-Analysis of Genome-Wide Studies
Bushman, F. D., Malani, N., Fernandes, J., D'Orso, I., Cagney, G., Diamond, T. L., Zhou, H., Hazuda, D. J., Espeseth, A. S., König, R., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000437 · Cited by 452
“Though indirect, these observations suggest a model in which splicing factors may help recruit integrase to active transcription units, which are favored for integration [46–48].”
BackgroundWang, G. P., Ciuffi, A., Leipzig, J., Berry, C. C., & Bushman, F. D. (2007) · Genome Research · doi:10.1101/gr.6286907 · Cited by 457
“HIV favors integration within active transcription units (Schroder et al. 2002; Wu et al. 2003; Mitchell et al. 2004; Barr et al. 2005, 2006; Ciuffi et al. 2005, 2006b; Lewinski et al. 2005, 2006).”
Safe harbours for the integration of new DNA in the human genome
Sadelain, M., Papapetrou, E. P., & Bushman, F. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3179 · Cited by 441
“These afford semi-random insertion spanning the entire genome with a high predilection for integration in the vicinity of transcribed genes, which accounts for about two-thirds of all integration”
BackgroundMechanisms of HBV-related hepatocarcinogenesis
Neuveut, C., Wei, Y., & Buendia, M. A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.033 · Cited by 421
“As previously shown for retroviruses [107,108], HBV DNA integration appears to occur frequently in actively transcribed chromosomal regions, within genes or at their immediate vicinity.”
BackgroundGenome-wide analysis of retroviral DNA integration
Bushman, F., Lewinski, M., Ciuffi, A., Barr, S., Leipzig, J., Hannenhalli, S., & Hoffmann, C. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1263 · Cited by 422
“However, chromosomal integration-site selection of retroviruses in vivo is not rando”
BackgroundViral Vectors for Gene Therapy: Translational and Clinical Outlook
Kotterman, M. A., Chalberg, T. W., & Schaffer, D. V. (2015) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-104938 · Cited by 424
Gargett, T., & Brown, M. P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00235 · Cited by 395
Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse
Collier, L. S., Carlson, C. M., Ravimohan, S., Dupuy, A. J., & Largaespada, D. A. (2005) · Nature · doi:10.1038/nature03681 · Cited by 406
Ex vivo gene transfer and correction for cell-based therapies
Naldini, L. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2985 · Cited by 358
“These events are even more likely in γ-retroviruses, which have a bias for integration near promoters of active gene”
BackgroundModlich, U., Navarro, S., Zychlinski, D., Maetzig, T., Knoess, S., Brugman, M. H., Schambach, A., Charrier, S., Galy, A., Thrasher, A. J., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.179 · Cited by 387
Silencing and Variegation of Gammaretrovirus and Lentivirus Vectors
Ellis, J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1241 · Cited by 379
“When this is done with data from Table 1 of Wu et al .”
Retroviral Elements and Their Hosts: Insertional Mutagenesis in the Mouse Germ Line
Maksakova, I. A., Romanish, M. T., Gagnier, L., Dunn, C. A., van de Lagemaat, L. N., & Mager, D. L. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020002 · Cited by 357
Lentiviral vectors: basic to translational
Sakuma, T., Barry, M. A., & Ikeda, Y. (2012) · Biochemical Journal · doi:10.1042/bj20120146 · Cited by 336
Mutagenesis and Oncogenesis by Chromosomal Insertion of Gene Transfer Vectors
Baum, C., Kustikova, O., Modlich, U., Li, Z., & Fehse, B. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.253 · Cited by 360
“MLV vectors show the strongest trend to integrate near transcription start sites, potentially increasing the risk of insertional gene activation (Wu et al ., 2003).”
Groner, A. C., Meylan, S., Ciuffi, A., Zangger, N., Ambrosini, G., Dénervaud, N., Bucher, P., & Trono, D. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000869 · Cited by 364
“HIV-derived vectors preferentially integrate in downstream regions of transcribed genes [42,43].”
BackgroundRetroviral DNA integration: viral and cellular determinants of target-site selection
Lewinski, M. K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., Hannenhalli, S., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020060 · Cited by 364
“MLV strongly favors integration near CpG islands while HIV does not [11,14].”
InfluentialHan, Y., Lassen, K., Monie, D., Sedaghat, A. R., Shimoji, S., Liu, X., Pierson, T. C., Margolick, J. B., Siliciano, R. F., & Siliciano, J. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6122-6133.2004 · Cited by 327
“vored sites of integration in two studies (54, 68), but when cells”
BackgroundResultInfluentialSinn, P. L., Sauter, S. L., & McCray, P. B. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302570 · Cited by 322
Wang, Z., Troilo, P. J., Wang, X., Griffiths, T. G., Pacchione, S. J., Barnum, A. B., Harper, L. B., Pauley, C. J., Niu, Z., Denisova, L., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302213 · Cited by 322
Cell culture assays reveal the importance of retroviral vector design for insertional genotoxicity
Modlich, U., Bohne, J., Schmidt, M., von Kalle, C., Knöss, S., Schambach, A., & Baum, C. (2006) · Blood · doi:10.1182/blood-2005-08-024976 · Cited by 278
“Hope for reduced insertional side effects of modified gene vectors resulted from earlier findings that lentiviruses and derived vectors integrate more frequently than gammaretroviral vectors into transcribed regions of active genes, but less frequently into promoter-proximal regions.(26,27) This is underlined by a lar…”
Craigie, R., & Bushman, F. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006890 · Cited by 327
“Subsequently, HIV integration site selection has been studied after acute infection in many cell types (Wu et al. 2003; Mitchell et al. 2004; Barr et al. 2006; Berry et al. 2006; Ciuffi et al. 2006; Wang et al. 2007; Brady et al. 2009a), and the favoring of integration in active transcription units has been seen in al…”
BackgroundClonal dominance of hematopoietic stem cells triggered by retroviral gene marking
Kustikova, O., Fehse, B., Modlich, U., Yang, M., Düllmann, J., Kamino, K., von Neuhoff, N., Schlegelberger, B., Li, Z., & Baum, C. (2005) · Science · doi:10.1126/science.1105063 · Cited by 283
Viral gene therapy strategies: from basic science to clinical application
Young, L. S., Searle, P. F., Onion, D., & Mautner, V. (2006) · The Journal of Pathology · doi:10.1002/path.1896 · Cited by 313
“These events have intensified investigation of the insertion site preferences of retroviruses; an MLV vector was shown to integrate preferentially within a few kbp either side of the transcription start site of active genes, in human cells [63], while HIV integration sites tend to be uniformly distributed within trans…”
BackgroundHigh-Resolution Genome-Wide Mapping of Transposon Integration in Mammals
Yant, S. R., Wu, X., Huang, Y., Garrison, B., Burgess, S. M., & Kay, M. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2085-2094.2005 · Cited by 318
“3), we also investigated whether SB integration showed any bias toward important regulatory sequences, as recently reported for recombinant MLV- and AAV-based vectors (36, 38, 39, 58).”
BackgroundResultInfluentialSelf-citationLlano, M., Vanegas, M., Fregoso, O., Saenz, D., Chung, S., Peretz, M., & Poeschla, E. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9524-9537.2004 · Cited by 305
“In contrast, Moloney murine leukemia virus (MoMLV) integrations show a predilection for promoter regions of genes (76).”
BackgroundInfluentialGenotoxicity of Retroviral Integration In Hematopoietic Cells
Nienhuis, A. W., Dunbar, C. E., & Sorrentino, B. P. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.001 · Cited by 258
Cherepanov, P., Devroe, E., Silver, P. A., & Engelman, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406307200 · Cited by 287
Genome-Wide Analysis of Chromosomal Features Repressing Human Immunodeficiency Virus Transcription
Lewinski, M. K., Bisgrove, D., Shinn, P., Chen, H., Hoffmann, C., Hannenhalli, S., Verdin, E., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.6610-6619.2005 · Cited by 270
“For all sets of HIV integration sites and all types of gene calls, integration was strongly biased in favor of transcription units (34, 40, 50).”
BackgroundMethodInfluentialLentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency
De Ravin, S. S., Wu, X., Moir, S., Kardava, L., Anaya-O’Brien, S., Kwatemaa, N., Littel, P., Theobald, N., Choi, U., Su, L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad8856 · Cited by 244
“6, and table S5) confirms LV’s preferential targeting of actively expressed genes and gene-dense regions (79% within genes versus 39% for random control) (24, 25) (discussed further in the Supplementary Materials andMethods).”
BackgroundMethodSelf-citationMcCormack, M. P., & Rabbitts, T. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032207 · Cited by 278
Retroviral insertional mutagenesis: past, present and future
Uren, A. G., Kool, J., Berns, A., & van Lohuizen, M. (2005) · Oncogene · doi:10.1038/sj.onc.1209043 · Cited by 271
“Insertions from MLV and HIV-1 infected cell lines (Schroder et al., 2002; Wu et al., 2003; Mitchell et al., 2004) and MLV and SIV infected primate haematopoietic precursors (Hematti et al., 2004) indicate that while both viruses preferentially insert into transcribed regions of the genome, MLV has…”
BackgroundHot spots of retroviral integration in human CD34+ hematopoietic cells
Cattoglio, C., Facchini, G., Sartori, D., Antonelli, A., Miccio, A., Cassani, B., Schmidt, M., von Kalle, C., Howe, S., Thrasher, A. J., et al. (2007) · Blood · doi:10.1182/blood-2007-01-068759 · Cited by 270
Hematti, P., Hong, B.-K., Ferguson, C., Adler, R., Hanawa, H., Sellers, S., Holt, I. E., Eckfeldt, C. E., Sharma, Y., Schmidt, M., et al. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020423 · Cited by 265
“This unexpected and highly nonrandom clustering raises several questions since recent mapping analyses in cell lines did not report any common integration site (Wu et al. 2003).”
BackgroundResultInfluentialEmiliani, S., Mousnier, A., Busschots, K., Maroun, M., Van Maele, B., Tempé, D., Vandekerckhove, L., Moisant, F., Ben-Slama, L., Witvrouw, M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501378200 · Cited by 242
Deichmann, A., Hacein-Bey-Abina, S., Schmidt, M., Garrigue, A., Brugman, M. H., Hu, J., Glimm, H., Gyapay, G., Prum, B., Fraser, C. C., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31659 · Cited by 256
Mutagenesis strategies in zebrafish for identifying genes involved in development and disease
AMSTERDAM, A., & HOPKINS, N. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.06.011 · Cited by 251
Aiuti, A., Cassani, B., Andolfi, G., Mirolo, M., Biasco, L., Recchia, A., Urbinati, F., Valacca, C., Scaramuzza, S., Aker, M., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31666 · Cited by 252
Lesbats, P., Engelman, A. N., & Cherepanov, P. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00125 · Cited by 233
Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned
Morgan, R. A., Gray, D., Lomova, A., & Kohn, D. B. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.10.010 · Cited by 245
“It is now known that gRVs tend to land near transcriptional start sites of genes, CpG islands, andDNase 1 hypersensitive sites (which tend to be transcriptionally active) (De Rijck et al., 2013; Derse et al., 2007; Emery et al., 2009; Mitchell et al., 2004; Wu et al., 2003).”
BackgroundSowd, G. A., Serrao, E., Wang, H., Wang, W., Fadel, H. J., Poeschla, E. M., & Engelman, A. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524213113 · Cited by 249
“MLV targets promoter regions and associated CpG islands to much greater extents than HIV-1 (47).”
BackgroundPhilippe, S., Sarkis, C., Barkats, M., Mammeri, H., Ladroue, C., Petit, C., Mallet, J., & Serguera, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606197103 · Cited by 249
Improved Tet-responsive promoters with minimized background expression
Loew, R., Heinz, N., Hampf, M., Bujard, H., & Gossen, M. (2010) · BMC Biotechnology · doi:10.1186/1472-6750-10-81 · Cited by 246
“This effect was less pronounced after viral transduction, possibly somewhat overridden by the preference of g-retroviral vectors for promoter-proximal integration [39] and the resulting elevated background expression levels.”
BackgroundIntegration Specificity of Phage ϕC31 Integrase in the Human Genome
Chalberg, T. W., Portlock, J. L., Olivares, E. C., Thyagarajan, B., Kirby, P. J., Hillman, R. T., Hoelters, J., & Calos, M. P. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.098 · Cited by 237
Foamy virus vector integration sites in normal human cells
Trobridge, G. D., Miller, D. G., Jacobs, M. A., Allen, J. M., Kiem, H.-P., Kaul, R., & Russell, D. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510046103 · Cited by 236
Themis, M., Waddington, S. N., Schmidt, M., von Kalle, C., Wang, Y., Al-Allaf, F., Gregory, L. G., Nivsarkar, M., Themis, M., Holder, M. V., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.07.358 · Cited by 243
“The target site selection in or near the coding regions of expressed genes has been described for a number of these vectors [2,4] whose parent viruses are known to be able potentially to up- or down-regulate gene expression after integration as well as to participate in the induction of oncogenesis [5–7].”
BackgroundSmith, J. R., Maguire, S., Davis, L. A., Alexander, M., Yang, F., Chandran, S., ffrench-Constant, C., & Pedersen, R. A. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0039 · Cited by 241
Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting
Marshall, H. M., Ronen, K., Berry, C., Llano, M., Sutherland, H., Saenz, D., Bickmore, W., Poeschla, E., & Bushman, F. D. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001340 · Cited by 241
“In support of this idea is the finding that MLV integration is strongly favored at start sites [28,57], while several other integrating elements show near random distributions [22,55,58], suggesting that mechanisms exist to guide preferential integration near start sites.”
The multifactorial nature of HIV-1 latency
Lassen, K., Han, Y., Zhou, Y., Siliciano, J., & Siliciano, R. F. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.006 · Cited by 235
Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting
De Paula, D., Bentley, M. V. L. B., & Mahato, R. I. (2007) · RNA · doi:10.1261/rna.459807 · Cited by 228
“Consequently , the use of adenoviral vectors is being explored since these vectors do not integrate into the host genome and efficiently transduce both dividing and nondividing cells (Wu et al. 2003).”
BackgroundThe lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication
Engelman, A., & Cherepanov, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000046 · Cited by 231
“The c-retrovirus MoMLV, in contrast to lentiviruses, prefers to integrate in the vicinity of transcription start sites and CpG islands [67,71], while a spumaretrovirus, simian foamy virus (SFV), is biased against integrating into genes, yet nonetheless displays significant preferences for gene start sites and CpG isla…”
BackgroundHIV-1 Latency in Monocytes/Macrophages
Kumar, A., Abbas, W., & Herbein, G. (2014) · Viruses · doi:10.3390/v6041837 · Cited by 217
“However, findings suggest that HIV-1 proviral DNA preferentially integrates into the euchromatin region [20,44,45].”
BackgroundEarly steps of retrovirus replicative cycle
Nisole, S., & Saïb, A. (2004) · Retrovirology · doi:10.1186/1742-4690-1-9 · Cited by 198
“have mapped 903 different integration sites of MLV, revealing preferential integration into highly transcribed genes [193].”
BackgroundAppraisal for the Potential of Viral and Nonviral Vectors in Gene Therapy: A Review
Butt, M., Zaman, M., Ahmad, A., Khan, R., Mallhi, T., Hasan, M., Khan, Y., Hafeez, S., Massoud, E., Rahman, M., et al. (2022) · Genes · doi:10.3390/genes13081370 · Cited by 210
“The genomic insertion point of these viruses was different from MLV vectors; thus, they showed a decreased occurrence of genotoxicity [27,28].”
BackgroundProgresses towards safe and efficient gene therapy vectors
Chira, S., Jackson, C. S., Oprea, I., Ozturk, F., Pepper, M. S., Diaconu, I., Braicu, C., Raduly, L.-Z., Calin, G. A., & Berindan-Neagoe, I. (2015) · Oncotarget · doi:10.18632/oncotarget.5169 · Cited by 219
“Indeed, the MoMLV shows an integration bias towards the start of transcriptional units [169, 170] and this has been proposed to be determined by the host transcriptional factors interaction with the enhancer elements in the LTR sequence, which synergize with the integration of the provirus in transcription units [171]…”
BackgroundNatural history of adult T-cell leukemia/lymphoma and approaches to therapy
Taylor, G. P., & Matsuoka, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208979 · Cited by 223
“Additionally, the frequency of integration into transcription units is 34.2% for murine leukemia virus (MLV), and these sites are clustered near the transcriptional Oncogene start sites (Wu et al., 2003).”
BackgroundInfluentialChance or necessity? Insertional Mutagenesis in Gene Therapy and Its Consequences
Baum, C., von Kalle, C., Staal, F. J. T., Li, Z., Fehse, B., Schmidt, M., Weerkamp, F., Karlsson, S., Wagemaker, G., & Williams, D. A. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.10.013 · Cited by 225
“This may explain why simple MLV-based vectors, which depend on mitosis for access to chromosomes, appear to have a propensity to insert in the vicinity of cellular promoters [15].”
BackgroundBushman, F. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00760-8 · Cited by 221
“Differential access to targets may well contribute to integra-viruses (Schroder et al., 2002; Wu et al., 2003) have hinted that there may be more parallels between retrovi- tion specificity, but such a model alone cannot account for different target preferences by MLV and HIV in theral and yeast…”
Background(2009) · PubMed
Nuclear Retention of Multiply Spliced HIV-1 RNA in Resting CD4+ T Cells
Lassen, K. G., Ramyar, K. X., Bailey, J. R., Zhou, Y., & Siliciano, R. F. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020068 · Cited by 216
“with recent studies of sites of HIV-1 integration [24,32,74,75], Figure 7.”
BackgroundAn infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors
Dong, B., Kim, S., Hong, S., Das Gupta, J., Malathi, K., Klein, E. A., Ganem, D., DeRisi, J. L., Chow, S. A., & Silverman, R. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610291104 · Cited by 219
Chromodomains direct integration of retrotransposons to heterochromatin
Gao, X., Hou, Y., Ebina, H., Levin, H. L., & Voytas, D. F. (2008) · Genome Research · doi:10.1101/gr.7146408 · Cited by 205
“Murine leukemia virus (MLV) shows a preference for promoter regions (Wu et al. 2003), and human immunodeficiency virus (HIV) integrates preferentially into actively transcribed genes at sites with transcription-associated histone modifications (Schroder et al. 2002; Wang et al. 2007).”
BackgroundVandekerckhove, L., Christ, F., Van Maele, B., De Rijck, J., Gijsbers, R., Van den Haute, C., Witvrouw, M., & Debyser, Z. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1886-1896.2006 · Cited by 208
“The integration of proviral HIV-1 genomes occurs preferentially in actively transcribed regions (31), in contrast to MoMLV, which preferentially integrates in the proximity of the promoter region (44).”
BackgroundHIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2
Ocwieja, K. E., Brady, T. L., Ronen, K., Huegel, A., Roth, S. L., Schaller, T., James, L. C., Towers, G. J., Young, J. A. T., Chanda, S. K., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001313 · Cited by 212
“show a preference for integration near gene 59 ends and CpG islands [13–15].”
BackgroundInfluentialDing, D., Lou, X., Hua, D., Yu, W., Li, L., Wang, J., Gao, F., Zhao, N., Ren, G., Li, L., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003065 · Cited by 209
“More recent studies, however, suggested that integration of various viruses into human genome has distinct preferences [29–31].”
BackgroundExperimental approaches to the study of HIV-1 latency
Han, Y., Wind-Rotolo, M., Yang, H.-C., Siliciano, J. D., & Siliciano, R. F. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1580 · Cited by 208
“, as is the case for sites in cell lines infected with HIV-1 in vitro”
The Interaction of LEDGF/p75 with Integrase Is Lentivirus-specific and Promotes DNA Binding
Busschots, K., Vercammen, J., Emiliani, S., Benarous, R., Engelborghs, Y., Christ, F., & Debyser, Z. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411681200 · Cited by 208
Resolving systematic errors in widely used enhancer activity assays in human cells
Muerdter, F., Boryń, Ł. M., Woodfin, A. R., Neumayr, C., Rath, M., Zabidi, M. A., Pagani, M., Haberle, V., Kazmar, T., Catarino, R. R., et al. (2018) · Nature Methods · doi:10.1038/nmeth.4534 · Cited by 208
Selection of Target Sites for Mobile DNA Integration in the Human Genome
Berry, C., Hannenhalli, S., Leipzig, J., & Bushman, F. D. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020157 · Cited by 201
“MLV Gamma retrovirus Hela-NS 917 Matched Integrants were not selected [9]”
BackgroundResultInfluentialEmbryonic and adult stem cell therapy
Brignier, A. C., & Gewirtz, A. M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.032 · Cited by 199
Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges
Cavazzana, M., Bushman, F. D., Miccio, A., André-Schmutz, I., & Six, E. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0020-9 · Cited by 199
Schwarzwaelder, K., Howe, S. J., Schmidt, M., Brugman, M. H., Deichmann, A., Glimm, H., Schmidt, S., Prinz, C., Wissler, M., King, D. J. S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31661 · Cited by 203
Cellular co-factors of HIV-1 integration
Van Maele, B., Busschots, K., Vandekerckhove, L., Christ, F., & Debyser, Z. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.002 · Cited by 185
Schambach, A., Bohne, J., Chandra, S., Will, E., Margison, G. P., Williams, D. A., & Baum, C. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.012 · Cited by 196
BET proteins promote efficient murine leukemia virus integration at transcription start sites
Sharma, A., Larue, R. C., Plumb, M. R., Malani, N., Male, F., Slaughter, A., Kessl, J. J., Shkriabai, N., Coward, E., Aiyer, S. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307157110 · Cited by 193
“To delineate the Brd3(1-726) segments (Fig.”
BackgroundResultInfluentialVisualization of monoaminergic neurons and neurotoxicity of MPTP in live transgenic zebrafish
Wen, L., Wei, W., Gu, W., Huang, P., Ren, X., Zhang, Z., Zhu, Z., Lin, S., & Zhang, B. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2007.11.012 · Cited by 189
Huang, X., Guo, H., Tammana, S., Jung, Y.-C., Mellgren, E., Bassi, P., Cao, Q., Tu, Z. J., Kim, Y. C., Ekker, S. C., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.141 · Cited by 183
Self-citationLarge‐scale molecular characterization of adeno‐associated virus vector integration in mouse liver
Nakai, H., Wu, X., Fuess, S., Storm, T. A., Munroe, D., Montini, E., Burgess, S. M., Grompe, M., & Kay, M. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3606-3614.2005 · Cited by 190
“(28, 32), the plasmid rescue approach we applied in the present study allowed us”
BackgroundMethodSelf-citationAcetylation of HIV‐1 integrase by p300 regulates viral integration
Cereseto, A., Manganaro, L., Gutierrez, M. I., Terreni, M., Fittipaldi, A., Lusic, M., Marcello, A., & Giacca, M. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600770 · Cited by 181
“Recently, broad analyses on integration site selection have indeed revealed that retroviruses preferentially integrate near transcriptionally active genes (Schroder et al, 2002; Wu et al, 2003; Mitchell et al, 2004).”
BackgroundMMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer
Theodorou, V., Kimm, M. A., Boer, M., Wessels, L., Theelen, W., Jonkers, J., & Hilkens, J. (2007) · Nature Genetics · doi:10.1038/ng2034 · Cited by 184
“However, some retroviral integration bias toward tissue-specific transcriptionally active regions may also be presen”
BackgroundRecchia, A., Bonini, C., Magnani, Z., Urbinati, F., Sartori, D., Muraro, S., Tagliafico, E., Bondanza, A., Stanghellini, M. T. L., Bernardi, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507496103 · Cited by 189
Metadata
- Authors
- Wu, X., Li, Y., Crise, B., & Burgess, S. M.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Burgess, Shawn M.
- Venue
- Science
- Published
- 2003-06-13
- Volume
- 300
- Issue
- 5626
- Pages
- 1749-1751
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1637867377
- Cited by
- 1,305
- References
- 18
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 11 · 2023: 13 · 2022: 18 · 2021: 25 · 2020: 27 · 2019: 33 · 2018: 24 · 2017: 39 · 2016: 43 · 2015: 49 · 2014: 65 · 2013: 51 · 2012: 83
- FWCI
- 57.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01co12400-79-0-22)
- National Cancer Institute (N01CO12400)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Chromosomal and Genetic Variations
- Keywords
- retroviral integration, transcription start sites, murine leukemia virus, HIV-1, human genome, gene therapy
- MeSH terms
- Child, Genetic Vectors, HeLa Cells, Humans, Leukemia, Leukemia Virus, Murine, Promoter Regions, Genetic, Transcription, Genetic, Tumor Cells, Cultured, Genetic Therapy, HIV-1, Gene Expression, Genome, Human, Virus Integration, CpG Islands, Oligonucleotide Array Sequence Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.